The IκB kinase β (IKKβ) is a prominent regulator of neuroinflammation, which is implicated in the pathogenesis of Huntington's disease (HD). Inflammatory mediators accumulate in the serum and CNS of premanifest and manifest HD patients, and cytokine levels correlate with disease progression. IKKβ may also directly regulate the neurotoxicity of huntingtin (Htt). Activation of IKKβ by DNA damage triggers caspase-dependent cleavage of WT and mutant Htt and enhances the accumulation of oligomeric fragments. Moreover, the N-terminal fragments of mutant Htt (HDx1) directly bind to and activate IKKβ. Thus, the IKKβ-dependent cleavage of full-length mutant Htt and the buildup of HDx1 could form a deleterious feed-forward loop. Elevated IKKβ activity is present throughout the CNS in a symptomatic mouse model of HD expressing HDx1, whereas in asymptomatic mice with full-length mutant Htt, it is confined to the striatum. IKKβ could also influence the phosphorylation of Htt at Ser13 and Ser16, which is linked to HD pathology. IKKβ inhibitors ameliorate the toxicity of mutant Htt in striatal neurons and prevent DNA damage-induced Htt cleavage. Inhibition of IKKβ in the CNS also reduces neuroinflammation and imparts neuroprotection in a chemical model of HD. These findings support an active role for IKKβ in HD pathogenesis and represent an example of how gene-environment (exemplified by DNA damage and inflammation) interactions can influence Htt neurotoxicity. We will summarize these findings and describe the therapeutic potentials of IKKβ for HD.
Introduction

Huntington's disease and IKKβ
HD is an inherited neurodegenerative disorder caused by expansion of a CAG repeat, which is translated into a polyglutamine (polyQ) stretch in exon-1 (HDx1) of Htt. (The Huntington's Disease Collaborative Research Group (1993) . In most animal and cellular models of HD, the neurotoxicity of mutant Htt is enhanced by the cleavage and production of N-terminal fragments, which are generated by various enzymes including caspases and calpains. The fragments containing expanded polyQ aberrantly bind to various proteins, impair cellular machinery, and promote neurotoxicity. The N-terminal mutant Htt fragments also form amorphous intracellular aggregates and accumulate in the HD brain. The role of these aggregates in the pathobiology of HD remains a contentious area of investigation. Wild type Htt is also cleaved by similar proteases, which can lower its level and interfere with its vital function in neurons. Therefore, both the loss of WT Htt and the gain of toxic functions by mutant Htt contribute to HD. Studies on the neurobiology of HD were extensively reviewed recently (Zuccato and Cattaneo, 2010) . Although expansion of polyQ is a determinant of HD, the age of disease onset is variable among patients with similar polyQ length (Wexler Neurobiology of Disease 43 (2011) 305-311 
